An individual randomised efficacy trial of autologous blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in leprosy in Nepal: the TABLE trial protocol
Abstract Background Leprosy is curable with multidrug therapy and treatment in the early stages can prevent disability. However, local nerve damage can lead to injury and consequently recurring and disfiguring ulcers. The aim of this study is to evaluate the treatment of leprosy ulcers using an auto...
Main Authors: | Indra B. Napit, Dilip Shrestha, Jon Bishop, Sopna Choudhury, Santosh Dulal, Paramjit Gill, Eleni Gkini, Holly Gwyther, Deanna A. Hagge, Karuna Neupane, Jo Sartori, Gemma Slinn, Samuel I. Watson, Richard Lilford |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05392-5 |
Similar Items
-
The potential application of platelet-rich fibrin (PRF) in vestibuloplasty
by: Mohammad Amin Amiri, et al.
Published: (2021-07-01) -
A technical note on contamination from PRF tubes containing silica and silicone
by: Richard J. Miron, et al.
Published: (2021-03-01) -
THE MANAGEMENT OF PERIAPICAL MAXILLARY CYST BY USING THE A-PRF (PLATELET RICH ADVANCED FIBRIN) A CASE REPORT
by: Mihaela Mitrea, et al.
Published: (2015-07-01) -
Cryptanalysis of AES-PRF and Its Dual
by: Patrick Derbez, et al.
Published: (2018-06-01) -
Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
by: Cortese Antonio, et al.
Published: (2017-03-01)